tcell
neoplasm
poor
prognosi
effect
therapeut
option
therefor
identif
factor
tcell
leukemialymphoma
associ
cancer
progress
may
repres
novel
therapeut
target
recent
studi
highlight
previous
unappreci
role
express
tolllik
receptor
tlr
cell
effect
cell
surviv
prolifer
tlr
bind
exogen
molecul
deriv
pathogen
well
endogen
selfligand
releas
damag
cell
recent
report
demonstr
tlr
engag
primari
mous
human
cell
enhanc
prolifer
andor
cell
surviv
mechan
tlr
stimul
cell
influenc
paramet
differ
tcell
subset
affect
tlr
stimul
current
investig
furthermor
neither
biolog
import
stimul
tlr
neoplast
cell
preval
tlr
express
tcell
malign
yet
character
base
publish
report
compel
preliminari
data
propos
activ
signal
pathway
neoplast
cell
contribut
diseas
progress
reduc
cell
death
enhanc
cell
divis
articl
present
theoret
argument
experiment
data
support
hypothesi
format
tlr
heterodim
aid
detect
broader
array
icrobi
product
tolllik
receptor
express
primarili
cell
innat
immun
system
dendrit
cell
dc
macrophag
b
cell
engag
tlr
exogen
ligand
function
danger
signal
immun
system
initi
cascad
signal
event
trigger
host
defens
depend
tlr
stimul
cell
type
activ
tlr
stimul
enhanc
immun
respons
induc
cytokin
product
augment
express
costimulatori
molecul
increas
cell
number
increas
cell
number
occur
enhanc
cell
divis
increas
cell
surviv
promot
gener
hematopoiet
precursor
use
tlr
agonist
develop
potent
antitumor
tcell
respons
subject
major
focu
recent
time
role
tlr
agonist
princip
believ
occur
stimul
tlr
profession
antigenpres
cell
activ
tcellmedi
immun
cancer
cell
distinguish
featur
tlr
agonist
aptitud
induc
express
variou
costimulatori
molecul
includ
enhanc
express
mhc
ii
induc
product
inflammatori
cytokin
eg
chemokin
necessari
expans
cell
although
activ
tlr
signal
antigenpres
cell
clearli
import
gener
vast
number
cell
emerg
data
numer
group
includ
indic
tlr
engag
directli
cell
promot
expans
tlr
express
profil
effect
differ
tlr
ligand
cell
vari
human
mous
well
divers
tcell
subset
effect
tlr
agonist
cell
summar
tabl
gener
howev
tlr
express
cell
heavili
influenc
activ
statu
ie
naiv
activ
memori
exampl
wherea
tlr
protein
bare
detect
absent
naiv
cell
tlr
express
function
detect
within
hour
tcell
activ
sourc
tcell
activ
capabl
confer
cell
tlr
function
includ
stimul
cognat
mhc
antigen
antibodi
concavalin
precis
interplay
tcell
activ
induct
tlr
express
known
howev
tcell
activ
may
induc
de
novo
synthesi
tlr
induc
express
tlr
signalingrel
molecul
adaptor
protein
recent
show
antigenmedi
tcell
activ
induc
gene
transcript
protein
express
moder
increas
express
level
furthermor
plausibl
tcell
activationdepend
signal
promot
transloc
tlr
intracellular
compart
cell
surfac
bind
tlr
ligand
memori
cell
appear
maintain
tlr
express
level
naiv
cell
lower
level
express
blast
cell
furthermor
unlik
naiv
cell
requir
concomit
cell
receptor
tcr
stimul
transduct
tlr
signal
human
memori
cell
shown
respond
agonist
even
absenc
tcr
signal
howev
simultan
tcr
stimul
significantli
enhanc
costimulatori
effect
tlr
stimul
alon
mansson
et
al
also
report
human
cell
freshli
isol
tonsil
express
elev
mrna
transcript
follow
infect
streptococci
cell
also
express
higher
protein
level
cell
howev
express
remain
similar
cell
among
variou
signal
tlr
engag
induc
cell
critic
import
tcell
neoplasm
enhanc
cell
surviv
prolifer
exampl
engag
helper
cell
augment
product
consequ
increas
prolifer
tabl
addit
tlr
stimul
shown
enhanc
durat
receptor
chain
express
bendig
et
al
demonstr
tlrligat
cell
circumv
requir
costimul
induc
product
prolifer
stress
effect
tlr
signal
cell
recent
studi
cottalorda
et
al
group
demonstr
stimul
cell
promot
tcell
expans
part
decreas
antigen
threshold
requir
induc
cell
divis
surviv
vitro
also
worth
note
tlr
signal
sever
cell
type
includ
cell
regul
protein
involv
cell
cycl
kinet
includ
regul
dtype
cyclin
cyclin
cyclindepend
kinas
addit
ligand
lipopolysaccharid
lp
purifi
regulatori
cell
treg
also
shown
augment
prolifer
induc
upregul
sever
activ
marker
interestingli
although
tcr
activ
augment
effect
lp
treg
respond
lp
stimul
even
absenc
signal
albeit
lower
extent
thu
unlik
helper
cell
cytotox
cell
treg
appear
requir
tcr
stimul
function
tlr
signal
stimul
human
treg
also
shown
augment
suppress
activ
polyg
oligodeoxi
nucleotid
ligat
treg
abrog
suppress
function
report
indic
agonist
eg
pam
cysk
promot
prolifer
mous
treg
studi
found
ligand
reduc
express
lower
suppress
activ
engag
tlr
cell
also
increas
cell
number
modul
express
apoptosisrel
molecul
instanc
gelman
colleagu
report
ligat
cell
augment
bclx
l
express
level
enhanc
cell
surviv
similarli
report
cell
express
higher
level
bclx
l
maintain
elev
level
molecul
despit
exposur
genotox
stress
cell
engag
increas
express
bclx
l
anoth
antiapoptot
molecul
addit
previou
work
group
demonstr
cell
obtain
ligandinject
mice
express
elev
level
bclx
l
compar
cell
obtain
control
mice
activ
cell
also
avoid
death
express
high
level
antiapotot
molecul
fasassoci
death
domainlik
enzymeinhibitori
protein
flip
interfer
format
deathinduc
signal
complex
document
cell
deriv
ligandtr
mice
resist
serum
deprivationand
activationinduc
cell
death
ex
vivo
furthermor
enhanc
tcell
surviv
associ
increas
express
level
flip
cell
altogeth
studi
emphas
prolif
prosurviv
effect
differ
tlr
distinct
tcell
subject
recent
demonstr
engag
impart
radioprotect
effect
activ
cell
radioprotect
effect
manifest
vitro
decreas
apoptosi
intriguingli
found
engag
increas
rate
dna
doublestrand
break
repair
associ
increas
activ
checkpoint
kinas
enhanc
express
antiapoptot
molecul
bclx
l
vivo
wildtyp
cell
display
greater
radioresist
cell
addit
sohn
et
al
report
agonist
protect
primari
mous
spleen
cell
well
human
macrophag
bcell
line
death
induc
radioprotect
also
accompani
increas
express
bclx
l
worth
highlight
howev
radioprotect
effect
observ
sohn
et
al
without
differenti
distinct
immun
cell
subset
therefor
whether
cell
amongst
protect
cell
subset
determin
collect
find
indic
tlr
agonist
reduc
apoptosi
howev
whether
activ
tlr
signal
tcell
neoplasm
contribut
radioresist
resist
form
anticanc
therapi
chemotherapi
remain
explor
cell
defici
express
trif
cell
alter
tcell
surviv
emphas
critic
specif
role
signal
cell
turka
colleagu
also
demonstr
need
express
order
cell
mount
effect
respons
gondii
infect
also
suggest
agonist
found
synovium
rheumatoid
arthriti
patient
aggrav
diseas
statu
stimul
cell
zaninzhorov
et
al
also
report
tlr
signal
human
cell
alter
migrat
capac
part
chang
express
level
chemokin
receptor
eg
sobek
colleagu
observ
activ
cell
agonist
sustain
pathogeninduc
chronic
inflammatori
joint
diseas
induc
tcell
prolifer
secret
physiolog
signific
signal
cell
highlight
recent
studi
group
found
coinject
cell
ligand
mice
improv
tcell
cytotox
increas
tcell
number
cell
mice
respond
agonist
result
suggest
increas
number
cell
aris
direct
stimul
cell
demonstr
costimulatori
effect
ligand
cell
occur
fashion
vivo
studi
expans
cell
vivo
found
neither
cell
respond
ligand
vivo
summari
accumul
evid
highlight
occurr
tlr
express
cell
variou
effect
tlr
stimul
divers
tcell
subset
wherea
engag
certain
tlr
enhanc
cytokin
product
tlr
agonist
augment
cell
surviv
prolifer
suppress
tcell
respons
mount
evid
also
suggest
activ
tlr
signal
cell
may
contribut
directli
pathophysiolog
certain
diseas
rheumatoid
arthriti
differ
effect
tlr
agonist
differ
tcell
subset
warrant
investig
role
signal
may
play
expans
surviv
tcell
neoplasm
follow
section
provid
overview
publish
report
support
hypothesi
signal
tcell
malign
may
contribut
diseas
progress
tcell
neoplasm
includ
sever
diseas
markedli
heterogen
biolog
present
natur
histori
therapi
tcell
leukemia
includ
tcell
acut
lymphoblast
leukemia
tall
tcell
prolymphocyt
leukemia
tpll
adult
tcell
leukemia
atll
tcell
larg
granular
lymphocyt
tlgl
leukemia
tcell
lymphoma
includ
peripher
tcell
lymphoma
otherwis
specifi
ptclno
cutan
tcell
lymphoma
ctlc
base
divers
biolog
diseas
import
prolif
antiapoptot
mechan
variabl
implic
acut
lymphoblast
leukemia
common
cancer
children
account
cancer
age
year
age
year
make
common
cancer
age
group
nearli
case
diagnos
annual
usa
total
all
children
adult
tall
histor
link
poor
prognosi
use
convent
cancer
therapi
togeth
strict
use
prognost
factor
result
overal
complet
remiss
rate
childhood
tall
adult
tall
poor
outcom
adult
patient
tall
associ
drug
resist
limit
effect
therapeut
option
specif
diagnost
marker
tcell
lineag
surfac
cytoplasm
express
cell
surfac
marker
may
express
tall
cell
includ
well
tcell
subset
marker
includ
thymocyt
helper
cell
cytotox
cell
given
heterogen
tcell
antigen
express
leukem
cell
consid
tcell
subset
express
distinct
tlr
express
profil
postul
expresss
tlr
tlrrelat
protein
might
util
mean
character
diseas
heterogen
support
assert
preliminari
data
group
indic
tall
cell
line
ccrfcem
express
figur
furthermor
engag
heterodim
pam
cysk
significantli
augment
prolifer
tall
line
figur
contrast
tlymphoma
line
express
low
level
figur
reduc
level
tlr
protein
correl
decreas
number
tlr
gene
transcript
shown
lack
respons
ligand
figur
current
probe
idea
level
tlr
proteinmrna
transcript
tcell
neoplasm
prolif
respons
tlr
agonist
malign
cell
associ
clinic
data
pretreat
characterist
respons
treatment
relaps
notch
signal
also
play
key
role
normal
tcell
develop
aberr
pathway
seen
malign
transform
estim
human
tall
activ
mutat
notch
signal
initi
extracellular
domain
receptor
bind
membranebound
ligand
neighbor
cell
includ
jaggedserr
famili
membranebound
ligand
engag
notch
ligand
lead
proteolyt
cleavag
releas
notch
intracellular
domain
cell
membran
notch
intracellular
domain
transloc
nucleu
form
complex
dna
bind
protein
csl
histon
acetyltransferas
hat
result
transcript
activ
notch
target
gene
intriguingli
activ
combin
tlr
ligand
shown
augment
ligand
express
dc
furthermor
lack
dc
significantli
reduc
express
level
ligand
although
link
tlr
signal
notch
signal
tcell
malign
remain
unknown
recent
studi
show
notch
signal
activ
tlr
stimul
macrophag
merit
investig
topic
inhibitor
gsi
block
notch
signal
clinic
trial
treatment
tall
specif
gsi
shown
block
proteolyt
activ
notch
receptor
interestingli
elzinga
report
character
conserv
consensu
bind
site
within
ilir
render
suscept
cleavag
also
target
instrument
signal
data
suggest
altern
mechan
gsi
inhibit
tall
progress
may
reduc
signal
howev
concept
yet
examin
approxim
tall
patient
display
increas
activ
pathway
result
activ
cytokin
signal
ie
andor
mutat
akt
pten
increas
activ
pathway
associ
cell
prolifer
surviv
drug
resist
recent
find
highlight
inhibit
pathway
reduc
prolifer
surviv
tall
recent
demonstr
activ
nonmalign
cell
result
part
enhanc
activ
mtor
pathway
inhibit
mtor
akt
cell
abolish
costimulatori
effect
agonist
data
suggest
constitut
activ
pathway
may
part
result
activ
tlr
signal
tcell
neoplasm
howev
concept
yet
demonstr
tcell
prolymphocyt
leukemia
rare
chronic
leukemia
repres
approxim
adult
chronic
lymphocyt
leukemia
character
prolifer
smalltomediums
prolymphocyt
immunophenotyp
tpll
cell
matur
postthym
cell
tdt
tcell
prolymphocyt
leukemia
cell
demonstr
structur
abnorm
involv
rearrang
tcell
leukemialymphoma
tcl
oncogen
locu
result
overexpress
highlevel
express
tcrexpress
tpll
associ
faster
cell
doubl
result
part
enhanc
respons
tcr
stimul
interestingli
tlr
costimul
cell
shown
significantli
lower
tcr
activ
threshold
result
increas
prolifer
whether
signal
amplifi
tcr
signal
alter
express
tpll
cell
whether
signal
play
import
role
tpll
surviv
andor
prolifer
merit
investig
adult
tcell
lymphomaleukemia
matur
peripher
tcell
malign
caus
human
tcell
lymphotroph
viru
htlv
pass
sexual
transmiss
mother
child
mainli
breastfeed
contamin
blood
product
infect
popul
estim
million
worldwid
approxim
femal
male
infect
develop
atll
one
signal
pathway
constitut
activ
cell
suggest
play
critic
role
prolifer
andor
surviv
base
fact
tlr
signal
pathway
activ
mizob
colleagu
investig
whether
signal
contribut
activ
htlvitransform
cell
author
found
constitut
associ
sever
htlvitransform
tcell
line
jurkat
infect
htlvi
furthermor
cell
transform
express
mrna
constitut
activ
inhibit
overexpress
dominantneg
form
result
reduc
prolifer
enhanc
apoptosi
data
highlight
indispens
role
surviv
htlvinfect
cell
furthermor
htlvi
tax
viral
protein
involv
allow
random
integr
provir
dna
host
genom
augment
tlr
express
could
activ
find
suggest
signal
may
contribut
constitut
activ
downstream
signal
event
activ
malign
cell
tlr
agonist
promot
tcell
expans
intriguingli
moarbess
et
al
found
molecul
close
relat
ligand
imidazoquinoxalin
inhibit
cell
prolifer
induc
apoptosi
fresh
atl
cell
well
htlvitransform
malign
cell
cell
healthi
individu
remain
resist
ligandmedi
apoptosi
treatment
associ
downmodul
sever
antiapoptot
protein
includ
bclx
l
loss
mitochondri
membran
integr
howev
despit
agonist
treatment
appear
alter
activ
suggest
tlrmediat
activ
may
primarili
associ
cell
surviv
adult
tcell
lymphomaleukemia
cell
also
express
tcell
antigen
usual
nearli
express
associ
b
chain
chain
form
high
affin
leukem
cell
atll
patient
shown
prolifer
respons
engag
variou
tlr
healthi
cell
enhanc
product
cytokin
augment
cell
divis
tabl
furthermor
activ
tlr
signal
cell
increas
express
level
cytokin
receptor
ie
tcell
surfac
prolong
durat
receptor
express
whether
tlr
signal
tcell
neoplasm
promot
divis
increas
cytokin
product
andor
receptor
express
remain
intrigu
question
yet
address
tcell
larg
granular
lymphocyt
leukemia
rare
indol
chronic
lymphoprolif
disord
character
clonal
expans
tlgl
typic
express
without
andor
clonal
tcr
gene
rearrang
pathogenesi
tlgl
leukemia
includ
presenc
chronic
antigen
stimul
result
persist
clone
antigendriven
termin
memori
effector
tlymphocyt
exogen
signal
cytokin
also
influenc
apoptosisrel
protein
express
role
tlr
signal
lgl
yet
determin
howev
previous
mention
tlr
activ
nonmalign
cell
recent
shown
increas
respons
antigen
stimul
result
increas
tcell
number
precis
mechan
tlr
signal
augment
tcell
number
known
like
involv
regul
apoptosisrel
molecul
induct
cytokin
cytokin
receptor
promot
cell
divis
support
claim
engag
activ
cell
increas
express
bclx
l
reduc
level
proapoptot
molecul
bim
ongo
studi
group
also
indic
overexpress
cell
significantli
augment
tcr
signal
enhanc
surviv
even
absenc
tlr
ligand
preliminari
data
agreement
emerg
studi
reveal
indispens
role
tcell
surviv
autoimmun
disord
rheumatoid
arthriti
aris
approxim
patient
tlgl
interestingli
studi
van
der
heijden
colleagu
found
agonist
synovium
rheumatoid
arthriti
costimul
tcell
respons
sobek
et
al
report
agonist
sustain
pathogeninduc
chronic
inflammatori
joint
diseas
induc
tcell
infiltr
prolifer
cytokin
product
observ
lead
us
question
whether
endogen
tlr
agonist
exacerb
autoimmun
tcellmedi
respons
may
also
promot
expans
malign
cell
stimul
signal
directli
leukemia
cell
constitut
activ
akt
jaksign
transduc
activ
transcript
stat
sphingolipidmedi
sphingosin
kinas
sphk
signal
tlgl
also
demonstr
recent
studi
quigley
et
al
group
demonstr
costimulatori
effect
signal
cell
unequivoc
depend
pathway
furthermor
cell
tlgl
patient
resist
fasmedi
apoptosi
similar
cell
deriv
mice
exhibit
resist
activationinduc
cell
death
increas
express
flip
data
underscor
similar
signal
profil
tlgl
cell
tlrstimul
cell
two
avail
treatment
demonstr
efficaci
seri
patient
tlgl
leukemia
immunosuppress
agent
cyclosporin
csa
lowdos
methotrex
produc
high
respons
rate
durabl
respons
csa
function
inhibit
calcineurin
respons
activ
transcript
factor
nfat
cell
suppress
nfat
result
reduc
tcell
prolifer
recent
studi
demonstr
calcineurin
also
neg
regul
tlr
signal
interact
trif
suggest
therapi
csa
may
also
function
reduc
tlgl
growth
inhibit
tlr
signal
pathway
tcell
lymphoma
current
includ
variou
subtyp
includ
ptclno
ctlc
ptcl
subtyp
nonhodgkin
lymphoma
nhl
aggress
cancer
gener
poor
prognosi
account
nonhodgkin
case
ctcl
rare
lymphoma
low
indol
account
approxim
nonhodgkin
diagnos
potenti
role
tlr
ptcl
ctlc
recent
begun
examin
smith
et
al
examin
express
mrna
level
found
highli
express
ptcl
cell
furthermor
immunostain
reveal
increas
number
cell
express
jarrouss
et
al
also
examin
express
level
sever
tlr
ctclsmycosi
fungoid
syndrom
differ
stage
diseas
use
paraffinembed
biopsi
found
cutan
lesion
express
higher
level
compar
normal
skin
mycosi
fungoid
show
increas
express
biopsi
syndrom
patient
also
demonstr
detect
level
although
express
level
tlr
effect
ligat
tlr
lymphoma
yet
character
suchin
et
al
describ
case
report
show
administr
topic
cream
contain
agonist
imiquimod
success
treat
stage
ia
ctlc
result
especi
encourag
consid
patient
respond
prior
treatment
number
topic
steroid
topic
nitrogen
mustard
carmustin
case
studi
emphas
divers
effect
tlr
agonist
highlight
tlr
agonist
may
promot
expans
tcell
neoplasm
tlr
ligand
may
induc
apoptosi
sever
studi
also
explor
whether
genet
differ
tlr
gene
influenc
hematopoiet
malign
nhl
hodgkin
lymphoma
hl
pathogenesi
mollaki
et
al
investig
associ
gene
polymorph
risk
hl
result
studi
demonstr
associ
gene
polymorph
risk
hl
purdu
et
al
examin
tlr
gene
variant
pool
analysi
nhl
case
control
found
two
variant
moder
linkag
disequilibrium
significantli
associ
nhl
risk
moreov
analysi
provid
evid
variant
may
influenc
suscept
margin
zone
lymphoma
studi
nieter
et
al
recogn
variant
link
increas
risk
follicular
lymphoma
reduc
risk
chronic
lymphocyt
leukemia
variant
also
associ
risk
hl
mucosaassoci
lymphoid
tissu
lymphoma
studi
suggest
effect
tlrtlrrelat
polymorph
variou
lymphoma
subtyp
last
decad
wit
import
advanc
field
tlr
research
variou
compound
develop
target
tlr
signal
treatment
sever
sepsi
variou
diseas
includ
antagonist
lp
rhodobact
sphaeroid
porphyromona
gingivali
word
eritoran
current
phase
iii
clinic
trial
treat
patient
sepsi
use
solubl
tlr
well
antibodi
neutral
tlr
antibodi
tlr
ligand
repres
anoth
potenti
effect
mean
inhibit
specif
tlr
signal
recent
insight
indic
sever
drug
alreadi
clinic
use
treat
cancer
allergi
chronic
infect
also
attenu
tlr
signal
exampl
statin
gener
use
lower
cholesterol
level
shown
inhibit
tlrmediat
inflammatori
respons
niessner
et
al
show
treatment
simvastatin
significantli
reduc
protein
express
monocyt
lower
level
healthi
volunt
meth
et
al
also
demonstr
treatment
statin
lower
express
level
associ
decreas
activ
monocyt
addit
pretreat
mice
cerivastatin
reduc
serum
level
respons
agonist
lp
angiotensinreceptor
blocker
candesartan
cilexetil
also
shown
tlr
antagonist
activ
candesartan
wide
use
treat
hypertens
sever
group
report
candesartan
also
attenu
inflamm
reduc
tlr
express
level
sanchezlemu
et
al
demonstr
treatment
candesartan
prior
lp
administr
decreas
gene
express
reduc
cytokin
product
vivo
dasu
et
al
demonstr
pretreat
monocyt
candesartan
reduc
express
mrna
protein
level
consequ
reduc
activ
express
similarli
candesartan
reduc
express
curb
respons
tlr
agonist
vivo
drug
glycyrrhizin
main
activ
compound
liquoric
also
found
antagon
tlr
signal
glycyrrhizin
use
treat
patient
variou
viralinduc
diseas
japan
exampl
glycyrrhizin
use
treat
patient
hepat
c
influenza
hivi
sever
acut
respiratori
syndrom
viru
although
precis
mechan
action
remain
undefin
glycyrrhizin
shown
imped
signal
result
reduct
proinflammatori
cytokin
glycyrrhizin
also
shown
inhibit
signal
transduct
respons
ligand
r
ecogn
recent
advanc
underscor
biolog
tlr
normal
cell
new
insight
provid
us
greater
appreci
divers
effect
differ
tlr
agonist
surviv
prolifer
variou
tcell
subset
ongo
studi
begin
reveal
potenti
role
tlr
signal
cell
suggest
tlr
may
play
import
role
pathogenesi
tcell
malign
tcell
leukemia
heterogen
group
disord
novel
improv
therapi
need
elucid
biolog
tlr
signal
tcell
neoplasm
potenti
lead
novel
target
therapi
malign
furthermor
evalu
sever
key
tlrrelat
molecul
could
help
establish
molecular
profil
distinct
tcell
leukemia
diseas
progress
andor
prognosi
therapyresist
patient
activ
tolllik
receptor
tlr
signal
nonmalign
cell
augment
cytokin
product
increas
prolifer
enhanc
cell
surviv
confer
radioresist
current
data
indic
malign
nonmalign
lymphocyt
express
function
tlr
depend
tlr
activ
cell
type
tlr
stimul
occur
engag
tlr
andor
signal
augment
cell
number
induc
apoptosi
assess
sever
key
tlrtlrrelat
molecul
could
help
establish
molecular
profil
distinct
tcell
leukemia
diseas
progress
andor
prognosi
therapyresist
patient
